New, Robust and Inexpensive Technique for Protein Analysis in Tissues

A new technique to study proteins, which does not require advanced equipment, specialized labs or expensive reagents, has been developed at Uppsala University, Sweden. The technique could be further developed to be used in point of care devices, for instance for diagnostic purposes. The possibility to identify and localize proteins in tissues is essential for understanding disease mechanisms and for diagnostics. However, today very advanced instruments are often needed to study proteins and how they interact with each other. An example is the microscopy technique that was awarded last year's Nobel Prize in chemistry; super resolution fluorescence microscopy.

Such equipment is expensive to purchase and often requires special training to handle. In order to use protein detection for diagnostic purposes, e.g. in a clinic, new, less complicated methods to study proteins are needed. Such methods should be temperature insensitive and not require expensive instruments, costly reagents or specially trained staff.

In the most recent issue of the journal Nature Communications the researchers present a technique that could be used by for instance hospital staff, to detect relevant proteins. The technique is based on the binding of antibodies, either to two sites on the same protein or to two proteins that are localized very close to each other. The antibodies have been linked to DNA strands that will attach to each other if they are close enough. When this happens a chain reaction will start in which increasing numbers of DNA strands are attached. To each DNA strand a fluorescent substance has been linked, which will emit light when it is irradiated with light of a certain wavelength.

"When the chain reaction has run for a while enough fluorescent molecules have been incorporated to allow us to observe them as very bright dots in a microscope, reflecting the presence of a protein of interest. The more dots there more protein," says Ola Söderberg, who has developed the technique together with Masood Kamali-Mogaddam and their research teams.

The chain reaction does not include any enzymes, which means that it can take place at room temperature. The microscopes needed to study the bright dots are relatively simple and commonly available in hospital and research labs. Since two antibodies are bound in the first step "false" signals can be avoided, making the reaction very specific for the studied protein.

"All this implies that our technique can be used as a robust and inexpensive method to localize proteins in tissues. We hope that it soon can be used both for clinical applications and for research purposes," says Ola Söderberg.

The technique has been developed in collaboration with researchers in Uppsala, Scotland and Austria. The results have been published online in the journal Nature Communications.

Reference: Proximity Dependent Initiation of Hybridization Chain Reaction, Nature Communications, DOI: 10.1038/ncomms8294

Science for Life Laboratory (SciLifeLab) is a national centre for molecular biosciences with the focus on health and environmental research. The centre combines advanced technical know-how and state-of-the art equipment with a broad knowledge of translational medicine and molecular bioscience.

Uppsala University - quality, knowledge, and creativity since 1477 World-class research and outstanding education of global benefit to society, business, and culture. Uppsala University is one of northern Europe's highest ranked academic institutions.

Most Popular Now

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...